Daily Bulletin

Men's Weekly

.

  • Written by Pitch Engine

​Asia-Pacific Haematology Market Outlook to 2021 is a new market research publication announced by Reportstack. This report provides key market data on the Asia-Pacific Haematology market. The report provides value, in millions of US dollars within market segments - Haematology Analyzers, Haemostasis, Haematology Reagents, Haematology Rapid Tests & POC, Haematology Cell Counters and Immunohaematology.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.

To access full report with TOC, please visit ​Asia-Pacific Haematology Market Outlook to 2021.

Scope

- Haematology market includes Haematology Analyzers, Haemostasis, Haematology Reagents, Haematology Rapid Tests & POC, Haematology Cell Counters and Immunohaematology.- Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.- 2014 company shares and distribution shares data for Haematology market.- Global corporate-level profiles of key companies operating within the Asia-Pacific Haematology market.- Key players covered include Danaher Corporation, Siemens Healthcare, Sysmex Corporation, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Immucor, Inc., Abbott Laboratories and bioMerieux S.A..

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.- Develop market-entry and market expansion strategies.- Design competition strategies by identifying who-stands-where in the market.- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Companies Mentioned

Sysmex Corporation Siemens Healthcare Danaher Corporation F. Hoffmann-La Roche Ltd. Horiba, Ltd. Abbott Laboratories Nihon Kohden Corporation Transasia Bio-Medicals Ltd. Mindray Medical International Limited bioMerieux S.A. Bio-Rad Laboratories, Inc. Immucor, Inc.

Contact:

Debora White

Manager - Marketing

debora@reportstack.com

Ph: +1-888-789-6604

​Reportstack Market Research

###

Authors: Pitch Engine

Read more http://www.pitchengine.com/pitches/42fa2055-0cd6-4129-8b29-36a74ba0122a

Business News

The ultimate checklist for launching a digital-first business

If you’re launching a business in 2025, chances are it’s going to be digital-first. Whether you’re running an online store, offering consulting services, or building something entirely new, they all h...

Daily Bulletin - avatar Daily Bulletin

“SMBs Are Building the Future While Australia Sleeps” — Marc Degli on AI, Innovation, and What Needs to Change

Australia’s startup scene has been called “emerging” for a decade — but for many founders, it still feels stalled. Government funding is mired in bureaucracy. Investors hedge their bets on “safe” deal...

Daily Bulletin - avatar Daily Bulletin

Hydrogen Pipe Infrastructure: A Guide to Future Networks

As Australia moves towards a cleaner energy future, hydrogen is emerging as a key player. But how do we get this promising energy source from production facilities to where it's needed? The answer l...

Daily Bulletin - avatar Daily Bulletin

LayBy Deals